Isocitrate dehydrogenase (IDH) inhibitor, Mutant IDH1-IN-1, Purity ≥98%

Synonym: 1355326-21-4; 2-(N-[2-(Benzimidazol-1-yl)acetyl]-3-fluoroanilino)-N-cyclohexyl-2-(2-methylphenyl)acetamide; 2-(N-[2-(Benzimidazol-1-yl)acetyl]-3-fluoroanilino)-N-cyclohexyl-2-(2-methylphenyl)acetamide; Isocitrate dehydrogenase (IDH) inhibitor

CAS Number: 1355326-21-4
Compound CID: 89696514

Product Size

5 mg; 10 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Mutant IDH1-IN-1 is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting isocitrate dehydrogenase (IDH). The molecular weight of the compound is 498.59, and its molecular formula is C₃₀H₃₁FN₄O₂.

Molecular Weight

498.59

Molecular Formula

C₃₀H₃₁FN₄O₂

Form

Lyophilized powder

Purity

≥98%

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Identity

Confirmed by NMR/HPLC/MS.

Applications

Mutant IDH1-IN-1 can be studied extensively for its potential therapeutic applications in the treatment of tumors with IDH1 mutations, such as gliomas and AML.